Cargando…
Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims
INTRODUCTION: There is limited real-world evidence on the treatments for atopic dermatitis (AD) since dupilumab was approved in 2017. The objective of this study was to assess market share of drugs commonly prescribed for the treatment of AD and describe treatment patterns in patients diagnosed with...
Autores principales: | Fenske, Christian, Boytsov, Natalie, Guo, Jiaying, Dawson, Zach |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056466/ https://www.ncbi.nlm.nih.gov/pubmed/35287230 http://dx.doi.org/10.1007/s12325-022-02071-y |
Ejemplares similares
-
US health care utilization and costs in adult patients with atopic dermatitis by disease severity
por: Wang, Xin, et al.
Publicado: (2022) -
The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021) -
Economic Burden of Atopic Manifestations in Patients With Atopic Dermatitis - Analysis of Administrative Claims
por: Suh, Dong-Churl, et al.
Publicado: (2007) -
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
por: Senna, Maryanne, et al.
Publicado: (2021) -
Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis
por: Hagenström, Kristina, et al.
Publicado: (2021)